12 Polen Capital Charles River Laboratories International Trades
The first Charles River Laboratories International trade was made in Q2 2022. Since then Polen Capital bought shares three more times and sold shares on eight occasions. The investor completely sold their stake between Q1 2024 and Q1 2025.
Avg closing price
Price range
Sold -4.25k shares
Q1 2025
Avg closing price
$167.66
Price range
$150.52
-
$190.14
Sold 22.8% shares (-1.26k shares)
Q4 2024
Avg closing price
$192.62
Price range
$178.58
-
$220.69
Sold 3.7% shares (-211 shares)
Q3 2024
Avg closing price
$207.57
Price range
$187.96
-
$245.29
Sold 5.7% shares (-345 shares)
Q2 2024
Avg closing price
$226.59
Price range
$206.39
-
$268.73
Sold 4.2% shares (-268 shares)
Q1 2024
Avg closing price
$238.81
Price range
$203.52
-
$273.43
Increased shares by 26.4% (+1.32k shares)
Q4 2023
Avg closing price
$196.66
Price range
$164.52
-
$238.84
Increased shares by 1.0% (+50 shares)
Q3 2023
Avg closing price
$205.30
Price range
$194.44
-
$217.61
Sold 9.4% shares (-514 shares)
Q2 2023
Avg closing price
$198.96
Price range
$183.71
-
$210.25
Sold 3.9% shares (-219 shares)
Q1 2023
Avg closing price
$226.63
Price range
$191.89
-
$259.92
Increased shares by 22.3% (+1.04k shares)
Q4 2022
Avg closing price
$218.37
Price range
$197.11
-
$250.07
Sold 0.7% shares (-35 shares)
Q3 2022
Avg closing price
$215.88
Price range
$182.44
-
$250.54
New holding (+4.69k shares)
Q2 2022
Avg closing price
$244.35
Price range
$204.13
-
$302.40
News about Charles River Laboratories International Inc. and Polen Capital
Charles River Laboratories sells Avian Vaccine Services business to Arlington Capital
Charles River Laboratories (CRL) has sold its Avian Vaccine Services business to private equity firm Arlington Capital Partners.The business, now AVS Bio, wi...
Softlogic Finances Growth Trajectory Backed by Shareholder Confidence
Zero NPLs on Rs. 14 Billion worth loans in a globally challenging year Colombo, June 30, 2021 Softlogic Finance PLC, a subsidiary of Softlogic Capital the f...